Neuronal nitric oxide synthase expression in cerebellar mutant mice

Cerebellum

Volumn 3, Issue 3, 2004, Pages 141-151

  Abbott, Louise C ^a   Nahm, Sang Soep ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Cerebellar mutant mice; Cerebellum; Granule cell; Nitric oxide; Purkinje cell

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID ETHYL ESTER; CALCIUM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PEROXYNITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BRAIN BLOOD FLOW; CEREBELLUM; CONTROLLED STUDY; GENE EXPRESSION; GRANULE CELL; KNOCKOUT MOUSE; LEARNING; LONG TERM DEPRESSION; MEMORY; MOUSE; MOUSE MUTANT; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PURKINJE CELL; SCHIZOPHRENIA; STELLATE CELL; SYNAPTOGENESIS;

ANIMALS; CEREBELLUM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; MICE, KNOCKOUT; MICE, NEUROLOGIC MUTANTS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I;

EID: 6344233083     PISSN: 14734222     EISSN: None     Source Type: Journal    
DOI: 10.1080/14734220410031927     Document Type: Article

References (128)

1. Bredt DS, Snyder SH. Nitric oxide, a physiological messenger molecule. Ann Rev Biochem 1994; 63: 175-195.
2. Culotta E, Koshland Jr. DE. NO news is good news. Science 1992; 258: 1862-1865.
3. Virgili M, Monti B, LoRusso A, Bentivogli M, Contestabile A. Developmental effects of in vivo and in vitro inhibition of nitric oxide synthase in neurons. Brain Res 1999; 839: 164-172.
4. Wang W, Nakayama T, Inoue N, Kato T. Quantitative analysis of nitric oxide synthase expressed in developing and differentiating rat cerebellum. Dev Brain Res 1998; 111: 65-75.
5. Drapier J-C, Ducrocq C. Introduction: molecular and functional modifications by nitric oxide and its derivatives. Cell Mol Life Sci 1999; 55: 1001-1002.
6. Palmer RM, Aston DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
7. Faraci FM, Brian JE. Nitric oxide and the cerebral circulation. Stroke 1994; 25: 692-703.
8. Gally JA, Montague RP, Reeke GN, Edelman GE. The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Nat Acad Sci 1990; 87: 3547-3551.
9. Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Ann Rev Physiol 1995; 57: 683-706.
10. Himi T, Ikeda M, Sato I, Yuasa T, Murota S. Purkinje cells express neuronal nitric oxide synthase after methylmercury administration. Brain Res 1996; 718: 189-192.
11. Holscher C. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci 1997; 20: 298-303.
12. Noda Y, Yamada K, Komori Y, Sugihara H, Furukawa H, Nabeshima T. Role of nitric oxide in the development of tolerance and sensitization to behavioral effects of phencyclidine in mice. Brit J Pharmacol 1996; 117: 1579-1585.
13. Ohyu J, Takashima S. Developmental characteristics of neuronal nitric oxide synthase (nNOS) immunoreactive neurons in fetal to adolescent human brains. Dev Brain Res 1998; 110: 193-202.
14. Schuman EM, Madison DV. Nitric oxide and synaptic function. Ann Rev Neurosci 1994; 17: 153-183.
15. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 2001; 64: 365-391.
16. Yang G, Huard JM, Beitz AJ, Ross ME, Iadecola C. Stellate neurons mediate functional hyperemia in the cerebellar molecular layer. J Neurosci 2000; 20: 6968-6973.
17. Dawson TM, Bredt DS, Synder SH. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 1992; 32: 297-311.
18. Leong S-K, Ruan R-S, Zhang Z. A critical assessment of the neurodestructive and neuroprotective effects of nitric oxide. Ann NY Acad Sci 2002; 962: 161-181
19. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. New Eng J Med 1993; 27: 2002-2012.
20. Boyd CS, Cadenas E. Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol Chem 2002; 383: 411-423.
21. Dawson VL, Dawson TM. Nitric oxide neurotoxicity. J Chem Neuroanat 1996; 10: 179-190.
22. Trenago M, Virgili M, Monti B, Guarnieri T, Contestabile A. Alteration of neuronal nitric oxide synthase activity and expression in the cerebellum and the forebrain of microencephalic rats. Brain Res 1998; 793: 54-60.
23. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Nat Acad Sci 1990; 87: 682-685.
24. Okada D. Differential effects of protein kinase C on neuronal nitric oxide synthase activity in rat cerebellar slices and in vitro. J Chem Neuroanat 1996; 10: 213-220.
25. Babbedge RC, Hart SL, Moore PK. Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA. J Pharm Pharmacol 1993; 45: 77-79.
26. Ikeda M, Matsui K, Ishihara Y, Morita I, Murota S-I, Yuasa T, Miyatake T. Cerebellar nitric oxide synthase, cGMP and motor function in two lines of cerebellar mutant mice, Staggerer and Wriggle Mouse Sagami. Neurosci Lett 1994; 168: 65-68.
27. Schilling K, Schmidt HHHW, Baader SL. Nitric oxide synthase expression reveals compartments of cerebellar granule cells and suggests a role for mossy fibers in their development. Neuroscience 1994; 59: 893-903.
28. Stojkovic T, Colin C, le Saux F, Jacque C. Specific pattern of nitric oxide synthase expression in glial cells after hippocampal injury. Glia 1998; 22: 329-337.
29. Catania MV, Aronica E, Yankaya B, Troost D. Increased expression of neuronal nitric oxide synthase spliced variants in reactive astrocytes of amyotrophic lateral sclerosis human spinal cord. J Neurosci 2001; 21: RC148(1-5).
30. Catania MV, Gluffrida R, Barbagallo G, Aronica E, Gorter JA, Dell'Albani, Ravagna A, Calabrese V, Gluffrida-Stella AM. Upregulation of neuronal nitric oxide synthase in in vitro stellate astrocytes and in vivo reactive astrocytes after electrically induced status epilepticus. Neurochem Res 2003; 28: 607-615.
31. Simic G, Lucassen PJ, Krsnik Z, Kruslin B, Kostovic I, Winblad B, Bogdanovi N. nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease. Exp Neurol 2000; 165: 12-26.
32. Jesko H, Chalimoniuk M, Strosznajder JB. Activation of constitutive nitric oxide synthase(s) and absence of inducible isoform in aged rat brain. Neurochem Internat 2003; 42: 315-322.
33. Henry Y, Guissani A. Interactions of nitric oxide with hemoproteins: roles of nitric oxide in mitochondria. Cell Mol Life Sci 1999; 55: 1003-1014.
34. Virgili M, Facchinetti F, Sparapani M, Tregnago M, Lucchi R, Dall'Olio R, Gandolfi O, Contestabile A. Neuronal nitric oxide synthase is permanently decreased in the cerebellum of rats subjected to chronic neonatal blockade of N-methyl-D-aspartate receptors. Neurosci Lett 1998; 258: 1-4.
35. Yu W-J, Juang S-W, Liu T-P, Cheng J-T. Decrease of neuronal nitric oxide synthase in the cerebellum of aged rats. Neurosci Lett 2000; 291: 37-40.
36. Balazs R, Jorgensen OS, Hack N. N-methyl-D-aspartate promotes the survival of cerebellar granule cells in culture. Neuroscience 1988; 27: 437-451.
37. Hermeneglido C, Montoliu C, Llanasola M, Munoz M-D, Gaztelu J-M, Minana M-D, Felipo V. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP in cerebellar neurons in culture and in the rat in vivo. Eur J Neurosci 1998; 10: 3201-3209.
38. Llansola M, Minana M-D, Montoliu C, Saez R, Corbalan R, Manzo L, Felipo V. Prenatal exposure to aluminum reduces expression of neuronal nitric oxide synthase and of soluble guanylate cyclase and impairs glutamatergic neurotransmission in rat cerebellum. J Neurochem 1999; 73: 712-718.
39. Yamada K, Nabeshima T. Two pathways of nitric oxide production through glutamate receptors in the rat cerebellum in vivo. Neurosci Res 1997; 28: 93-102.
40. Hernandez-Viadel M, Montoliu C, Monfort P, Canales JJ, Erceg S, Rowan M, Ceccatelli S, Felipo V. Chronic exposure to 2,5-hexanedione impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in rat brain in vivo. Neurochem International 2003; 42: 525-533.
41. Kitano T, Matsumura S, Seki T, Hikida T, Sakimura K, Nagano T, Mishina M, Nakanishi S, Ito S. Characterization of N-methyl-D-aspartate receptor subunits involved in acute ammonia toxicity. Neurochem International 2004; 44: 83-90.
42. Chen G, Dunbar RL, Gao W, Ebner TJ. Role of calcium, glutamate neurotransmission, and nitric oxide in spreading acidification and depression in the cerebellar cortex. J Neurosci 2001; 21: 9877-9887.
43. Okada D. Protein kinase C modulates calcium sensitivity of nitric oxide synthase in cerebellar slices. J Neurochem 1995; 64: 1298-1304.
44. Morton DB, Bredt DS. Norepinephrine increases cyclic GMP levels in cerebellar cells from neuronal nitric oxide synthase knockout mice. J Neurochem 1998; 71: 440-443.
45. Smith SL, Otis TS. Persistent changes in spontaneous firing of Purkinje neurons triggered by the nitric oxide signaling cascade. J Neurosci 2003; 23: 367-372.
46. Wall MJ. Endogenous nitric oxide modulates GABAergic transmission to granule cells in adult rat cerebellum. J Neurosci 2003; 18; 869-878.
47. Frisch D, Dere E, De Souza Silva MA, Godecke A, Schrader J, Huston JP. Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum. J Neurosci 2000; 20: 6694-6700.
48. Rodrigo J, Alonso D, Fernandez AP, Serrano J, Richart A, Lopez JC, Santacana M, Martinez-Murillo R, Moncada S, Bentura ML, Ghiglione M, Uttenthal LO. Neuronal and inducible nitric oxide synthase expression and protein nitration in rat cerebellum after oxygen and glucose deprivation. Brain Res 2001; 909: 20-45.
49. Liu B, Gao H-M, Wang J-Y, Jeohn G-H, Cooper CL, Hong J-S. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann NY Acad Sci 2002; 962: 318-331.
50. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxylradical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Nat Acad Sci 1990; 87: 1620-1624.
51. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Nat Acad Sci 1989; 86: 9030-9033.
52. Chabrier P-E, Demerle-Pallardy C, Auguet M. Nitric oxide synthases: Targets for therapeutic strategies in neurological diseases. Cell Mol Life Sci 1999; 55: 1029-1035.
53. Serrano J, Encinas JM, Salas E, Fernandez AP, Castro-Blanco S, Fernandez-Vizarra P, Bentura ML, Rodrigo J. Hypobaric hypoxia modifies constitutive nitric oxide synthase activity and protein nitration in the rat cerebellum. Brain Res 2003; 976: 209-229.
54. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH, Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 1997; 42: 644-654.
55. Good PF, Werner P, Hsu A, Olanow CW, Perl DP. Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996; 149: 21-28.
56. Good PF, Hsu A, Werner P, Perl DP, Olanow CW. Protein nitration in Parkinson's disease. Exp Neurol 1998; 57: 338-342.
57. Chalimoniuk M, Strosznajder J. NMDA receptor-dependent nitric oxide and cGMP synthesis in brain hemispheres and cerebellum during reperfusion after transient forebrain ischemia in gerbils: Effect of 7-nitroindazole. J Neurosci Res 1998; 54: 681-690.
58. Estevez AG, Jordan J. Nitric oxide and superoxide, a deadly cocktail. Ann NY Acad Sci 2002; 962: 207-211.
59. Mohanakumar KP, Thomas B, Sharma SM, Chiueh DD. Nitric oxide - An antioxidant and neuroprotector. Ann NY Acad Sci 2002; 962: 389-401.
60. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Nat Acad Sci 1993; 90: 9808-9812.
61. Macleod MR, Butcher SP. Nitric-oxide-synthase-mediated cyclic guanosine monophosphate production in neonatal rat cerebellar prisms is resistant to calcineurin inhibition. Neurosci Lett 2002; 322: 41-44.
62. Ciani E, Guidi S, Bartesaghi R, Contestabile A. Nitric oxide regulates cGMP-dependent cAMP-responsive protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide. J Neurochem 2002; 82: 1282-1289.
63. Gudi T, Casteel DE, Vinson C, Boss GR, Pilz RB. NO activation of fos promotor elements requires nuclear translocation of G-kinase I and CREB phosphorylation but is independent of MAP kinase activation. Oncogene 2000; 19: 6324-6333.
64. Ciani E, Virgili M, Contestabile A. Akt pathway mediates a cGMP-dependent survival role of nitric oxide in cerebellar granule neurons. J Neurochem 2002; 81: 218-228.
65. Hayashi T, Katsumi Y, Mukai T, Inoue M, Nagahama Y, Oyanagi C, Yamauchi H, Shibasaki H, Fukuyama H. Neuronal nitric oxide has a role as a perfusion regulator and a synaptic modulator in cerebellum but not in neocortex during somatosensory stimulation-An animal PET study. Neurosci Res 2002; 44: 155-165.
66. Yamamoto M, Schwarting GA, Crandall JE. Altered 9-0 acetylation of disialogangliosides in cerebellar Purkinje cells of the nervous mutant mouse. Brain Res 1994; 662: 223-232.
67. Ma J, Meng W, Ayata C, Huang PL, Fishman MC, Moskowitz MA. L-NNA-sensitive regional cerebral blood flow augmentation during hypercapnia in type III NOS mutant mice. Am J Physiol 1996; 271: H1717-H1719.
68. Fletcher CF, Lutz CM, O'Sullivan TN, Shaughnessy Jr. JD, Hawkes R, Frankel WN, Copeland NG, Jenkins NA. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996; 87: 607-617.
69. rol). J Neurosci 2000; 20: 5654-5662.
70. Levitt P, Noebels JL. Mutant mouse tottering: Selective increase of locus coeruleus axons in a defined single-locus mutation. Proc Nat Acad Sci 1981; 78: 4630-4634.
71. la) mice. Neuroscience 1999; 90: 717-728.
72. Suh YS, Oda S, Kang YH, Kim H, Rhyu IJ. Apoptotic cell death of cerebellar granule cells in rolling mouse Nagoya. Neurosci Lett 2002; 325: 1-4.
73. Zwingman TA, Neumann PE, Noebels JL, Herrup K. Rocker is a new variant of the voltage-dependent calcium channel gene Cacna1a. J Neurosci 2001; 21: 1169-1178.
74. Isaacs KR, Abbott LC. Development of the paramedian lobule of the cerebellum in wild type and tottering mice, Dev Neurosci 1992; 14: 386-393.
75. Heckroth JA, Abbott LC. Purkinje cell loss from alternating sagittal zones in the cerebellum of leaner mutant mice. Brain Res 1994; 658: 93-104.
76. Herrup K, Wilczynski SL. Cerebellar cell degeneration in the leaner mutant mouse. Neuroscience 1982; 7: 2185-2196.
77. Lau FC. Apoptosis, reduced intracellular free calcium level and altered gene expression in the cerebellum of the leaner mutant mouse. PhD Dissertation, Texas A&M University, College Station, Texas, 1999.
78. 1A calcium ion channel mutant mouse, leaner. Neuroscience 2003; 118: 667-680.
79. Dove LS, Nahm SS, Murchison D, Abbott LC, Griffith WH. Altered calcium homeostasis in cerebellar Purkinje cells of leaner mutant mice. J Neurophys 2000; 84: 513-524.
80. Rhyu IJ, Nahm S, Hwang SJ, Kim H, Suh YS, Oda SI, Frank TC, Abbott LC. Altered neuronal NOS expression in the cerebellum of calcium channel mutant mice. Brain Res 2003; 977: 129-140.
81. Doulazmi M, Hadj-Sahraoui N, Frederic F, Mariani J. Diminishing Purkinje cell populations in the cerebella of aging heterozygous Purkinje cell degeneration but not heterozygous nervous mice. J Neurogenet 2002; 16(2): 111-123.
82. Landis SC. Histochemical demonstration of mitochondrial dehydrogenases in developing normal and nervous mutant mouse Purkinje cells. J Histochem Cytochem 1975; 23: 136-143.
83. Brion JP, Guilleminot J, Nunez J. Dendritic and axonal distribution of the microtubule-associated proteins MAP2 and tau in the cerebellum of the nervous mutant mouse. Dev Brain Res 1988; 44: 221-232.
84. Ikeda M, Morita I, Murota S-I, Sekiguchi F, Yuasa T, Miyatake T. Cerebellar nitric oxide synthase activity is reduced in nervous and Purkinje cell degeneration mutants by not in climbing fiber-lesioned mice. Neurosci Lett 1993; 155: 148-150.
85. Fernandez-Gonzalez A, La Spada AR, Treadaway J, Higdon JC, Harris BS, Sidman RL, Morgan JI, Fernandez-Gonzalez J-Z. Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene, Nna1. Science 2002; 295: 1904-1906.
86. Strazielle C, Lalonde R, Hebert C, Reader TA. Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study. Neuroscience 1999; 94: 287-304.
87. Gillardon F, Baurle J, Wickert H, Grusser-Cornehls, Zimmermann M. Differential regulation of bcl-2, bax, c-fos, junB, and krox-24 expression in the cerebellum of Purkinje cell degeneration mutant mice. J Neurosci Res 1995; 41: 708-715.
88. Herrup K. Role of staggerer gene in determining cell number in cerebellar cortex. I. Granule cell death is an indirect consequence of staggerer gene action. Dev Brain Res 1983; 11: 267-274.
89. Hamilton BA, Frankel WN, Kerrebrock AW, Hawkins TL, FitzHugh W, Kusumi K, Russell LB, Mueller KL, van Berkel V, Birren BW, Kruglyak L, Lander ES. Disruption of the nuclear hormone receptor RORα in staggerer mice. Nature 1996; 379: 736-739.
90. Jarvis CI, Staels B, Brugg BB, Lemaigre-Dubreuil Y, Tedgui A, Mariani J. Age-related phenotypes in the staggerer mouse expand the ROR alpha nuclear receptor's role beyond the cerebellum. Mol Cell Endocrin 2002; 186: 1-5.
91. Steinmayr M, Andre E, Conquet F, Rondi-Reig L, Delhaye-Bouchaud N, Auclair N, Daniel H, Crepel F, Mariani J, Sotelo C, Becker-Andre M. Staggerer phenotype in retinoid-related orphan receptor α-deficient mice. Proc Nat Acad Sci 1998; 97: 3960-3965.
92. Besnard S, Silvestre J-S, Duriez M, Bakouche J, Lemaigre-Dubreuil Y, Mariani J, Levy BI, Tedgui A. Increased ischemia-induced angiogenesis in the staggerer mouse, a mutant of the nuclear receptor Rorα. Circ Res 2001; 89: 1209-1215.
93. Lau P, Bailey P, Dowhan DH, Muscat GEO. Exogenous expression of a dominant negative RO Nucleic. Acids Res 1999; 27: 411-420.
94. Meyer T, Kneissel M, Mariani J, Fournier B. In vitro and in vivo evidence for orphan nuclear receptor ROR alpha function in bone metabolism. Proc Nat Acad Sci 2000; 97: 9197-9202.
95. Inoue Y, Matsumura Y, Inoue K, Ichikawa R, Takayama C. Abnormal synaptic architecture in the cerebellar cortex of a new dystonic mutant mouse, Wriggle Mouse Sagami. Neurosci Res 1993; 16: 39-48.
96. 2+-ATPase gene causes deafness in Wriggle Mouse Sagami. Biochem Biophys Res Comm 1999; 261: 773-778.
97. Ikeda M, Mikuni M, Nishikawa T, Takahasi K. A neurochemical study of a new mutant mouse presenting myoclonus-like involuntary movement: a possible model of spontaneous serotonergic hyperactivity. Brain Res 1989; 495: 337-348.
98. Ishikawa K, Shibanoki S, Kubo T, Kogure M, Imamura Y, Osawa N, Ohmura M, Mikoshiba K. Functional difference in monoamine transmitters in the behaviorally abnormal mouse mutant (wriggle mouse sagami). Neurosci Lett 1989; 103: 343-348.
99. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75: 1273-1286.
100. Lev-Ram V, Nebyelul Z, Ellisman MH, Huang PL, Tsien RY. Absence of cerebellar long-term depression in mice lacking neuronal nitric oxide synthase. Learning Memory 1997; 3: 169-177.
101. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994; 265: 1883-1885.
102. Idecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997; 17: 9157-9164.
103. Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Nat Acad Sci 1996; 93: 4565-4571.
104. Schulz JB, Huang PL, Russell TM, Passov D, Fishman MC, Beal MF. Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J Neurochem 1996; 67: 430-433.
105. Yang G, Zhang Y, Ross ME, Iadecola C. Attenuation of activity-induced increases in cerebellar blood flow in mice lacking neuronal nitric oxide synthase. Am J Physiol 2003; 285: H298-H304.
106. Wu W, Liuzzi FJ, Schinco FP, Depto AS, Li Y, Mong JA, Dawson TM, Snyder SH. Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injury. Neuroscience 1994; 61: 719-726.
107. Saitoh O, Courchesne E. Magnetic resonance imaging study of the brain in autism. Psychiatry Clin Neurosci 1998; 52 Suppl: S219-S222.
108. Katsetos CD, Hyde TM, Herman MM. Neuropathology of the cerebellum in schizophrenia-an update: 1996 and future directions. Biol Psychiatry 1997; 42: 213-224.
109. Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter M, Lantos PA. Clinicopathological study of autism. Brain 1998; 121: 889-905.
110. Fatemi SH, Halt AR, Realmuto G, Earle J, Kist DA, Thuras P, Merz A. Purkinje cell size is reduced in cerebellum of patients with autism. Cell Mol Neurobiol 2002; 22: 171-175.
111. Kern JK. Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev 2003; 25: 377-382.
112. Fatemi SH, Cuadra AE, El-Fakahany EE, Sidwell RW, Thuras P. Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport 2000; 11: 1493-1496.
113. D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995; 374: 719-723.
114. Caviness Jr. VS, Rakic P. Mechanisms of cortical development: a view from mutations in mice. Ann Rev Neurosci 1978; 1: 297-326.
115. Mikoshiba K, Terada S, Takamatsu K, Shimai K, Tsukada Y. Histochemical and immunohistochemical studies of the cerebellum from the reeler mutant mouse. Dev Neurosci 1983; 6: 101-110.
116. Fatemi SH, Stary JM, Egan EA. Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder. Cell Mol Neurobiol 2002; 22: 139-152.
117. Fatemi SH. Reelin mutations in mouse and man: From reeler mouse to schizophrenia, mood disorders, autism and lissence-phaly. Mol Psychiatry 2001; 6: 129-133.
118. Ichimiya T, Okubo Y, Suhara T, Sudo Y. Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia. Biol Psychiatry 2001; 49: 20-27.
119. Levitt JJ, McCarley RW, Nestor PG, Petrescu C, Donnino R, Hirayasu Y, Kikinis R, Jolesz FA, Shenton ME. Quantitative volumetric MRI study of the cerebellum and vermis in schizophrenia: clinical and cognitive correlates. Am J Psychiatry 1999; 156: 1105-1107.
120. Loeber RT, Cintron CM, Yurgelun-Todd DA. Morphometry of individual cerebellar lobules in schizophrenia. Am J Psychiatry 2001; 158: 952-954.
121. Tran KD, Smutzer GS, Doty RL, Arnold SE. Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. Am J Psychiatry 1998; 155: 1288-1290.
122. Andersen BB, Pakkenberg B. Stereological quantitation in cerebella from people with schizophrenia. Brit J Psychiatry 2003; 182: 354-361.
123. Bernstein HG, Krell D, Braunewell KH, Baumann B, Gundel-finger ED, Diekmann S, Danos P, Bogerts B. Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia. J Neurocytol 2001; 30: 661-670.
124. Karson CN, Griffin WS, Mrak RE, Husain M, Dawson TM, Snyder SH, Moore NC, Sturner WQ. Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis. Mol Chem Neuropath 1996; 27: 275-284.
125. Tashiro H, Suzuki SO, Hitotsumatsu T, Iwaki T. An autopsy case of spinocerebellar ataxia type 6 with mental symptoms of schizophrenia and dementia. Clin Neuropath 1999; 18: 198-204.
126. Klockgether T, Evert B. Genes involved in hereditary ataxias. Trends Neurosci 1998; 21: 413-418.
127. 2+ channel defects in migraine, ataxia and epilepsy. Trends Pharm Sci 1999; 19: 121-127.
128. Abbott LC, Jacobowitz DM. Development of calretinin-immunoreactive unipolar brush-like cells and an afferent pathway to the embryonic and early postnatal mouse cerebellum. Anat Embryol 1995; 191: 541-559.